| 561 - 571 |
Solid lipid nanoparticles (SLNs) derived from para-acyl-calix[9]-arene: preparation and stability
Jebors S, Leydier A, Wu QZ, Ghera BB, Malbouyre M, Coleman AW |
| 572 - 582 |
Enhanced therapeutic effect of LK-423 in treating experimentally induced colitis in rats when administered in colon delivery microcapsules
Smrdel P, Cerne M, Bogataj M, Urleb U, Mrhar A |
| 583 - 593 |
Scale-up of a suspension-like polymerization process for the microencapsulation of phase change materials
Sanchez-Silva L, Carmona M, de Lucas A, Sanchez P, Rodriguez JF |
| 594 - 601 |
Incorporation of obidoxime into human serum albumin nanoparticles: optimisation of preparation parameters for the development of a stable formulation
Kufleitner J, Worek F, Kreuter J |
| 602 - 608 |
Liposomes and lipopolymeric carriers for gene delivery
de Ilarduya CT, Garcia L, Duzgunes N |
| 609 - 617 |
Ivermectin-loaded microparticles for parenteral sustained release: in vitro characterization and effect of some formulation variables
Camargo JA, Sapin A, Daloz D, Maincent P |
| 618 - 627 |
Formulation and in vitro evaluation of ciprofloxacin containing niosomes for pulmonary delivery
Moazeni E, Gilani K, Sotoudegan F, Pardakhty A, Najafabadi AR, Ghalandari R, Fazeli MR, Jamalifar H |
| 628 - 639 |
Formulation of wax oxybenzone microparticles using a factorial approach
Gomaa YA, Darwish IA, Boraei NA, El-Khordagui LK |
| 640 - 656 |
Preparation and evaluation of fast-release mephenamic acid microspheres
Etman M, Farid R, Nada A, Ebian A |
